Gastroenterology Learning Network

Jessica Salwen Deremer, PhD, on Insomnia in IBD by Gastroenterology Learning Network

Christina Ha, MD, on Biosimilars in IBD: Here to Stay by Gastroenterology Learning Network

Dr Rieder available and upcoming therapies and positioning of medications for Crohn disease.

Dr Cross, director of the University of Maryland IBD Program, discusses options for caring for patients with acute severe ulcerative colitis who require hospitalization.

Dr Ha reviews issues surrounding fertility, pregnancy, and breastfeeding among women with inflammatory bowel disease.

In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross, talk to Dr Sara Horst as they recap the abstract from the ECCO’23 Congress on ozanimod to help listeners understand how to utilize the drug to achieve better clinical responses in treating inflammatory bowel disease. Raymond Cross, MD, is professor of medicine and director of the IBD Program at the University of Maryland School...

Christina Ha, MD, on the Use of Biosimilars in IBD by Gastroenterology Learning Network

Raymond Cross, MD, on Care for the Hospitalized Patient With Ulcerative Colitis by Gastroenterology Learning Network

Raymond Cross, MD, on S1Ps for Treatment of IBD by Gastroenterology Learning Network

Gut Check host Dr Brian Lacy from the Mayo Clinic—Florida talks with Brooks Cash, MD, from the University of Texas Health Sciences Center in Houston about food allergies and food sensitivities.

Dr Cleveland, from the University of Chicago, reviews the use of intestinal ultrasound for the monitoring of inflammatory bowel disease and the significant advantages of this noninvasive, point-of-care technology for patients and clinicians alike.

Drs Wallach and Rosenbaum discuss their study into the trends of IBD incidence among children in New York City during the COVID-19 pandemic, and their surprising findings.

In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk with Dr Peter Higgins from the University of Michigan about the etiology of inflammatory bowel disease, including what is and what is not known, the hygiene hypothesis, and the (possible) role of the family dog.

Dr Livanos discusses research she and colleagues conducted showing that a specific antigen may be detected up to 10 years before development of ulcerative colitis.

Dr Adam Faye elaborates on how antibiotic exposure puts adults aged 40 years and older at an increased risk for developing inflammatory bowel disease. Adam Faye, MD, is an assistant professor of medicine and population health at the inflammatory bowel disease center at NYU Langone Health.

In this podcast, Dr Walter Chen sheds light on chronic gastrointestinal issues arising as a result of COVID-19 infection. Brian Lacy, MD, is a professor of medicine and gastroenterologist at the Mayo Clinic in Jacksonville, Florida. Walter Chen, MD, is an associate professor of medicine in the division of gastroenterology and hepatology at the Brigham and Women’s Hospital in Boston, Massachusetts.

In this episode of IBD Drive Time, Dr Samir Shah talks with hosts Raymond Cross, MD, and Millie Long, MD, about his term as president of the American College of Gastroenterology and the addition of services to benefits both providers and patients as well as advances in IBD therapy and '80s music!

In this episode of IBD Drive Time, Dr Bharati Kochar, an expert in studying frailty in older patients, speaks about inflammatory bowel disease among older patients. Dr Kochar, Dr Ray Cross and Dr Millie Long also discuss considerations in medication to manage IBD in times of the ongoing COVID-19 pandemic.

In this episode of IBD Drive Time, Dr Bharati Kochar, an expert in studying frailty in older patients, speaks about inflammatory bowel disease among older patients. Dr Kochar, Dr Ray Cross and Dr Millie Long also discuss considerations in medication to manage IBD in times of the ongoing COVID-19 pandemic. Millie Long, MD, is professor of medicine, vice-chief for Education and Fellowship Program di...

In this episode of IBD Drive Time, host Raymond Cross, MD, talks with Asher Kornbluth, MD, about choosing and monitoring therapies for inflammatory bowel disease from among the growing number of options.

Dr Mehandru reviews results of a study he and colleagues conducted at the Icahn School of Medicine in New York that examined the durability of response to p19 inhibitors among patients with IBD.

Dr Hudesman reviews the findings of a post hoc analysis to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction that he and his colleagues conducted.

In part 2 of their podcast, Drs Alan Bonder and Juan Pablo Arab review treatment for alcohol-related liver disease, including transplantation, and the importance of multidisciplinary care incorporating both treatment of ALD and treatment for alcohol use disorder.

In the first of 2 podcasts, Drs Alan Bonder and Juan Pablo Arab discuss the prevalence of alcohol-related liver disease, the conditions that may present, and how the population of patients has changed over time.

Dr Allegretti, from Brigham and Women's Hospital in Boston, talks with our hosts Raymond Cross, MD, and Millie Long, MD, on the risks of Clostridioides difficile among patients with inflammatory bowel disease, balancing treatment for the infection and IBD, and what's new in fecal microbiotal transplantation.